ArticleEuropean journal of medical research2022
Preadmission assessment of extended length of hospital stay with RFECV-ETC and hospital-specific data.
Article in European journal of medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.
- Hospital length of stay prediction tools for all hospital admissions and general medicine populations: systematic review and meta-analysis.Frontiers in medicine · 2023Pooled it
- Variational Bayes machine learning for risk adjustment of general outcome indicators with examples in urology.NPJ digital medicine · 2024Article
- Using large administrative data for mining patients' trajectories for risk stratification: An example from urological diseases.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients who exceed their expected length of stay in the hospital come at a cost to stakeholders in the healthcare sector as bed spaces are limited for new patients, nosocomial infections increase and the outcome for many patients is hampered due to multimorbidity after hospitalization.
objectivesThis paper develops a technique for predicting Extended Length of Hospital Stay (ELOHS) at preadmission and their risk factors using hospital data.
methodsA total of 91,468 records of patient's hospital information from a private acute teaching hospital were used for developing a machine learning algorithm relaying on Recursive Feature Elimination with Cross-Validation and Extra Tree Classifier (RFECV-ETC). The study implemented Synthetic Minority Oversampling Technique (SMOTE) and tenfold cross-validation to determine the optimal features for predicting ELOHS while relying on multivariate Logistic Regression (LR) for computing the risk factors and the Relative Risk (RR) of ELOHS at a 95% confidence level.
resultsAn estimated 11.54% of the patients have ELOHS, which increases with patient age as patients < 18 years, 18-40 years, 40-65 years and ≥ 65 years, respectively, have 2.57%, 4.33%, 8.1%, and 15.18% ELOHS rates. The RFECV-ETC algorithm predicted preadmission ELOHS to an accuracy of 89.3%. Age is a predominant risk factors of ELOHS with patients who are > 90 years-PAG (> 90) {RR: 1.85 (1.34-2.56), P: < 0.001} having 6.23% and 23.3%, respectively, higher likelihood of ELOHS than patient 80-90 years old-PAG (80-90) {RR: 1.74 (1.34-2.38), P: < 0.001} and those 70-80 years old-PAG (70-80) {RR: 1.5 (1.1-2.05), P: 0.011}. Those from admission category-ADC (US1) {RR: 3.64 (3.09-4.28, P: < 0.001} are 14.8% and 70.5%, respectively, more prone to ELOHS compared to ADC (UC1) {RR: 3.17 (2.82-3.55), P: < 0.001} and ADC (EMG) {RR: 2.11 (1.93-2.31), P: < 0.001}. Patients from SES (low) {RR: 1.45 (1.24-1.71), P: < 0.001)} are 13.3% and 45% more susceptible to those from SES (middle) and SES (high). Admission type (ADT) such as AS2, M2, NEWS, S2 and others {RR: 1.37-2.77 (1.25-6.19), P: < 0.001} also have a high likelihood of contributing to ELOHS while the distance to hospital (DTH) {RR: 0.64-0.75 (0.56-0.82), P: < 0.001}, Charlson Score (CCI) {RR: 0.31-0.68 (0.22-0.99), P: < 0.001-0.043} and some VMO specialties {RR: 0.08-0.69 (0.03-0.98), P: < 0.001-0.035} have limited influence on ELOHS.
conclusionsRelying on the preadmission assessment of ELOHS helps identify those patients who are susceptible to exceeding their expected length of stay on admission, thus, making it possible to improve patients' management and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.